文献速递呼吸危重症与机械通气

早期危重症骨骼肌代谢表型研究

Metabolic phenotype of skeletal muscle in early critical illness.
PubMed 文献 · Thorax · 2018-07-06

该研究对63例重症患者第1天和第7天进行股外侧肌活检和血清采样,发现线粒体β氧化酶浓度和线粒体生物发生标志物下降,肌肉ATP含量降低,AMPK磷酸化比值升高,肌肉内炎症因子增加,血清脂联素和胃饥饿素升高。结论认为线粒体生物发生减少和脂质氧化失调导致骨骼肌生物能量状态受损,肌肉内炎症与合成代谢恢复受损相关。

要点

  • 早期危重症患者骨骼肌线粒体生物发生和β氧化酶浓度下降。
  • 肌肉ATP含量降低,AMPK磷酸化比值升高,提示生物能量应激。
  • 肌肉内炎症与合成代谢恢复受损相关,脂质输注未改善能量状态。

核心结论

  • 线粒体生物发生减少和脂质氧化失调导致骨骼肌生物能量状态受损。
  • 肌肉内炎症与合成代谢恢复受损相关,脂质输注在生物能量上无活性。

研究设计与样本

  • 研究纳入63例重症患者(59%男性,54.7±18.0岁,APACHE II评分23.5±6.5),第1天和第7天采集股外侧肌活检和血清样本。

主要发现

  • 第1天至第7天,线粒体β氧化酶浓度下降,PGC1α mRNA表达变化-27.4CN(95%CI -123.9至14.3;n=23;p=0.025),线粒体DNA拷贝数变化-1859CN(IQR -5557至1325;n=35;p=0.032)。
  • 第1天肌肉ATP含量为17.7mmol/kg干重(95%CI 15.3至20.0),低于对照组的21.7mmol/kg干重(95%CI 20.4至22.9),p<0.001;7天内下降-4.8mmol/kg干重(IQR -8.0至1.2;n=33;p=0.001)。
  • 磷酸化AMPK与总AMPK比值增加0.52(IQR -0.09至2.6;n=31;p<0.001)。
  • 肌肉内磷酸胆碱增加847.2AU(IQR 232.5至1672;n=15;p=0.022),肿瘤坏死因子受体1增加0.66µg(IQR -0.44至3.33;n=29;p=0.041),IL-10增加13.6ng(IQR 3.4至39.0;n=29;p=0.004)。
  • 血清脂联素增加10.3µg(95%CI 6.8至13.7;p<0.001),胃饥饿素增加16.0ng/mL(IQR -7至100;p=0.028)。

临床怎么用

  • 关注危重症患者早期骨骼肌线粒体功能和生物能量状态。
  • 脂质输注可能无法改善肌肉生物能量状态,需谨慎评估。
  • 未来临床工作应聚焦于改善急性骨骼肌消耗的关键领域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To characterise the sketetal muscle metabolic phenotype during early critical illness. METHODS: Vastus lateralis muscle biopsies and serum samples (days 1 and 7) were obtained from 63 intensive care patients (59% male, 54.7±18.0 years, Acute Physiology and Chronic Health Evaluation II score 23.5±6.5). MEASUREMENTS AND MAIN RESULTS: From day 1 to 7, there was a reduction in mitochondrial beta-oxidation enzyme concentrations, mitochondrial biogenesis markers (PGC1α messenger mRNA expression (-27.4CN (95% CI -123.9 to 14.3); n=23; p=0.025) and mitochondrial DNA copy number (-1859CN (IQR -5557-1325); n=35; p=0.032). Intramuscular ATP content was reduced compared tocompared with controls on day 1 (17.7mmol/kg /dry weight (dw) (95% CI 15.3 to 20.0) vs. 21.7 mmol/kg /dw (95% CI 20.4 to 22.9); p<0.001) and decreased over 7 days (-4.8 mmol/kg dw (IQR -8.0-1.2); n=33; p=0.001). In addition, the ratio of phosphorylated:total AMP-K (the bioenergetic sensor) increased (0.52 (IQR -0.09-2.6); n=31; p<0.001). There was an increase in intramuscular phosphocholine (847.2AU (IQR 232.5-1672); n=15; p=0.022), intramuscular tumour necrosis factor receptor 1 (0.66 µg (IQR -0.44-3.33); n=29; p=0.041) and IL-10 (13.6 ng (IQR 3.4-39.0); n=29; p=0.004). Serum adiponectin (10.3 µg (95% CI 6.8 to 13.7); p<0.001) and ghrelin (16.0 ng/mL (IQR -7-100); p=0.028) increased. Network analysis revealed a close and direct relationship between bioenergetic impairment and reduction in muscle mass and between intramuscular inflammation and impaired anabolic signaling. ATP content and muscle mass were unrelated to lipids delivered. CONCLUSIONS: Decreased mitochondrial biogenesis and dysregulated lipid oxidation contribute to compromised skeletal muscle bioenergetic status. In addition, intramuscular inflammation was associated with impaired anabolic recovery with lipid delivery observed as bioenergetically inert. Future clinical work will focus on these key areas to ameliorate acute skeletal muscle wasting. TRIAL REGISTRATION NUMBER: NCT01106300.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Puthucheary ZA, Astin R, Mcphail MJW, et al. Metabolic phenotype of skeletal muscle in early critical illness. Thorax. 2018. PMID: 29980655. doi:10.1136/thoraxjnl-2017-211073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。